Feb. 2 at 4:24 PM
$CLNN reposting this to improve morale -
“This study showed not only paraclinical evidence of remyelination and improved axonal function, but measurable improvements in previously fixed deficits that we really haven’t seen any therapy in MS do,” said Michael Barnett, MBBS, PhD. Dr. Barnett is lead author of VISIONARY-MS Long-Term Extension: A Multi-Centre, Open-Label Long-Term Extension Study of CNM-Au8 in Patients with Stable Relapsing Multiple Sclerosis. “We saw an improvement and this was, for me, very unexpected,” said Dr. Barnett, professor of neurology at the Brain and Mind Centre, the University of Sydney, and Royal Prince Alfred Hospital, Sydney. “This therapy does not regenerate nerves or axons, but I suspect what it is doing is improving axonal function and therefore allowing electrical conduction through those nerve fibers that contribute to the greater amplitude of the response.” https://www.medcentral.com/neurology/ms/multiple-sclerosis-study-shows-cnm-au8-effective-in-remyelination
